Fig. 3From: PEGylated recombinant human hyaluronidase (PEGPH20) pre-treatment improves intra-tumour distribution and efficacy of paclitaxel in preclinical modelsRepresentative images of the different tissue architecture of SKOV3 and SKOV3/HAS3 tumours after PEGPH20 and PTX treatment. A H&E staining, 100x; B Alcian Blue staining with nuclear red counterstain, 200x magnification; C representative HA staining images and D HA quantification in the different experimental groups (*Student's t-test: p-value< 0.05; **Student's t-test: p-value< 0.01)Back to article page